Science news articles about 'receptor tyrosine kinases'

... and ephrin ligand family in human cancer is receiving increasing attention. Compared with other Eph receptors, EphA4 is distinguished by its ability to bind to both type A ephrins and most type B ...

... poor prognosis. Although pre-clinical studies indicated therapeutics inhibiting a group of proteins known as receptor tyrosine kinases (RTKs) would likely be beneficial to ...

... eager to test." ErbB2 and Brk go hand-in-hand ErbB2 is a member of a family of enzymes called receptor tyrosine kinases -- cell-surface molecules that goad cells into proliferating ...

... tumor suppressor pathway, which is involved in response to DNA damage and cell death; and the receptor tyrosine kinase pathway that carries signals that control cell growth. Chin said that the most ...

... the long-standing mystery of what Agrin binds to at the developing junction to activate the receptor tyrosine kinase MuSK," says molecular biologist Martin Raff of the MRC laboratory for Molecular ...

... generic stem cells. (The cocktails include inhibitors of GSK3, MEK, and FGF receptor tyrosine kinases.) Most importantly, the isolated cells can produce high rates of chimerism when reintroduced into ...

... is a highly potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. It is an investigational, oral agent that is administered once daily. Using a form of magnetic ...

... relevant to the human embryonic stem cells. For example, the team found that phosphoproteins in receptor tyrosine kinase (RTK) signaling pathways were numerous in undifferentiated hESCs. Follow-up ...